Not Signed In -
Respiratory Diseases |
Lung Diseases; Pleurisy |
Clinical Trial: Effectiveness of the Acute Respiratory Infection Smart Form
This study is not yet open for patient recruitment.
Verified by Agency for Healthcare Research and Quality (AHRQ) October 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Respiratory Tract Infections | Behavior: Antibiotic prescribing rates |
MedlinePlus related topics: Lung Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment
Official Title: Evaluating Smart Forms and Quality Dashboards in an EHR: Effectiveness of the Acute Respiratory Infection Smart Form
Secondary Outcomes: Appropriateness of antibiotic prescribing, re-visit rates, antibiotic costs, use of antibiotics, all-cause antibiotic use, quality of documentation
Expected Total Enrollment: 20000
Study start: November 2005; Expected completion: September 2007
Last follow-up: August 2007; Data entry closure: August 2007
Specific Aim 1: To design and implement an integrated documentation-based clinical decision support and physician feedback system, provided in an electronic health record (EHR), to improve the management of patients with acute medical conditions.
Hypothesis 1: A documentation-based clinical decision support tool (CDSS) “smart form” physician feedback system, can be designed and implemented to facilitate documentation and physician order-entry, provide individualized, evidence-based recommendations for the management of patients acute respiratory infections (ARIs), and are usable by primary care physicians.
Specific Aim 2: To determine the effectiveness of documentation-based CDSS and physician feedback on documentation and the clinical management of patients respiratory tract infections.
Hypothesis 2A: A documentation-based CDSS “smart form” will increase the documentation of important clinical data in patients with ARI when compared to usual practice.
Hypothesis 2B: A documentation-based CDSS “smart form” will increase adherence with guidelines for the management of patients with ARI when compared to usual practice.
Eligibility
Inclusion Criteria:
All patients of physicians participating in the study
Exclusion Criteria:
Any patients who are not part of a panel of a participating physician
Location and Contact Information
Jeffrey A. Linder, MD, MPH jlinder@partners.org
Blackford Middleton, MD, MPH, MSc, Principal Investigator, Partners Healthcare Systems Inc
More Information
Last Updated: December 8, 2005
Record first received: October 6, 2005
ClinicalTrials.gov Identifier: NCT00235040
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2006-01-10
Resources
- Adult (Acute) Respiratory Distress Syndrome (ARDS) (American Lung Association)
- African Americans and Lung Disease (American Lung Association)
email this page
print this page
bookmark this page
feedback on this page
